CCCCC4 Therapeutics, Inc.
$2.85+26% 1Y
$2.85
$1.7152 weeks$4.67
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Price is −9% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CCCC is trading
C4 Therapeutics, Inc. is +26% over the past year while the S&P 500 is +18%: 7.7 points ahead of the market.
+26%
1-year return · S&P 500 +18%
- vs 200-day average
- −9.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 31
RSI (14) · neutral
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-08
- $2.85
- 1 monthS&P 500 +1.6%
- −17%
- 1 yearS&P 500 +18%
- +26%
- 5 yearsS&P 500 +86%
- −94%
- vs 50-day average$3.58
- −20%
- 52-week high
- $4.67
- 52-week low
- $1.71
- Annualised volatility
- 92%
| Year | Return |
|---|---|
| 2026 (year to date) | +49% |
| 2025 | −47% |
| 2024 | −36% |
| 2023 | −4.2% |
| 2022 | −82% |
| 2021 | −2.8% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +3.7% |
| Feb | 6 | 3 of 6 | +13% |
| Mar | 6 | 1 of 6 | −19% |
| Apr | 6 | 2 of 6 | −15% |
| May | 6 | 3 of 6 | +3.1% |
| Jun | 6 | 4 of 6 | +0.18% |
| Jul | 6 | 5 of 6 | +24% |
| Aug | 6 | 3 of 6 | −0.09% |
| Sep | 6 | 1 of 6 | −12% |
| Oct | 6 | 2 of 6 | −2.4% |
| Nov | 6 | 3 of 6 | +1.6% |
| Dec | 6 | 1 of 6 | +25% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.